null
Share
Journal Information

Articles in press

Articles in press are accepted, peer reviewed articles that are not yet assigned to volumes/issues, but are citable using DOI. More info

Postoperative adjuvant chemoradiotherapy versus postoperative adjuvant radiotherapy for head and neck squamous cell carcinoma with adverse pathology: a systematic review and meta-analysis
Gabriela Garcia Korczaguin, Gilberto Vaz Teixeira, Ashok Shaha
10.1016/j.bjorl.2024.101516
Highlights

  • Overall and disease-free survival are greater in the adjuvant chemoradiation group.

  • Head and neck cancer recurrence is lower in the adjuvant chemoradiation group.

  • The rate of metastasis does not significantly differ between the adjuvant groups.

  • The rate of late toxicity does not significantly differ between the adjuvant groups.

  • The rate of acute skin toxicity is lower in the adjuvant chemoradiation group.

Full text access
Uncorrected Proof. Available online 4 October 2024
Pre-clinical training, technical adjustment and human case experience of transoral robotic surgery using Versius System
Guilherme Reimann Agne, Gustavo Nunes Bento, Marcelo Belli, Gustavo Becker Pereira, Renan Bezerra Lira, Leandro Luongo Matos, Luiz Paulo Kowalski
10.1016/j.bjorl.2024.101515
Highlights

  • Transoral Robotic Surgery is well-established using the DaVinci system.

  • Transoral robotic surgery with the Versius System is currently in its initial stage.

  • A mannequin model was effective for training and setup configuration.

  • The first human case demonstrated feasibility and excellent results.

  • In our preliminary experience, Versius proved to be a promising robotic system.

Full text access
Uncorrected Proof. Available online 4 October 2024
Brazilian Society of Otology task force – cochlear implant ‒ recommendations based on strength of evidence
Robinson Koji Tsuji, Rogério Hamerschmidt, Joel Lavinsky, Felippe Felix, Vagner Antonio Rodrigues Silva
10.1016/j.bjorl.2024.101512
Highlights

  • Hearing preservation in Cochlear Implant (CI) surgery should be encouraged.

  • Even for patients with auditory nerve mutations, CI can still be recommended.

  • Despite gene therapy in preliminary studies with OTOF gene, CI is still indicated.

  • Patients with surgical wound infection should be evaluated and treated as quickly.

Full text access
Uncorrected Proof. Available online 18 September 2024
Analysis of the role of IL-1 family and related genes in head and neck squamous cell carcinoma
Gaofei Yin, Wei Guo, Rong Wang, Nuan Li, Xiaohong Chen, Yang Zhang, Zhigang Huang
10.1016/j.bjorl.2024.101484
Highlights

  • Using databases to analyze IL-1 and related genes for their relevance in HNSCC.

  • We found IL18RAP and SIGIRR are highly expressed in HPV+ tumors.

  • IL18RAP, IL36A and SIGIRR were found to be prognostic protective factors.

  • IL-1A, IL1RAP, IL18RAP and SIGIRR affect the prognosis by CD8+ T-cell infiltration.

Full text access
Uncorrected Proof. Available online 12 September 2024
Serum HOTTIP expression is upregulated in nasopharyngeal carcinoma patients and predicts poor prognosis
Ding-Ting Wang, Jian Luo, Hua-Jun Feng, Yuan-Yuan Wang
10.1016/j.bjorl.2024.101471
Highlights

  • HOTTIP was highly expressed in the serum of Nasopharyngeal Carcinoma (NPC).

  • HOTTIP expression were related to the PFS and OS of NPC patients.

  • High HOTTIP expression was an independent risk factor for PFS in NPC patients

  • HOTTIP promoted the proliferation of NPC cells and inhibited cells apoptosis.

Full text access
Uncorrected Proof. Available online 22 July 2024
Effectiveness of acupuncture in individuals with tinnitus: randomized controlled trial
Marcelo Yugi Doi, Simone Sayomi Tano, Adriane Rocha Schultz, Luciana Lozza de Moraes Marchiori
10.1016/j.bjorl.2014.12.011
Open access
Available online 4 December 2015
Brazilian Journal of Otorhinolaryngology (English Edition)
Announcement Nota importante
Articles submitted as of May 1, 2022, which are accepted for publication will be subject to a fee (Article Publishing Charge, APC) payment by the author or research funder to cover the costs associated with publication. By submitting the manuscript to this journal, the authors agree to these terms. All manuscripts must be submitted in English.. Os artigos submetidos a partir de 1º de maio de 2022, que forem aceitos para publicação estarão sujeitos a uma taxa (Article Publishing Charge, APC) a ser paga pelo autor para cobrir os custos associados à publicação. Ao submeterem o manuscrito a esta revista, os autores concordam com esses termos. Todos os manuscritos devem ser submetidos em inglês.